Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C2 - Lewy Body Dementia

Saturday 04/02/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Melissa Armstrong, MD, MSc, FAAN
Aging, Dementia, Cognitive, and Behavioral Neurology
Participants should be able to recognize prodromal presentations of Lewy body dementia; be able to review assessments and biomarkers used in the clinical diagnosis of Lewy body dementia, including recent FDA approvals; and be able to identify pharmacologic and non-pharmacologic approaches to treating individuals with Lewy body dementia.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge
Intermediate
Fellow, Resident, General Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:35 AM PDT Speaker Recognizing Prodromal Lewy Body Dementia and Making the Diagnosis
Samantha K. Holden, MD, MS, FAAN
07:00 AM - 09:00 AM PDT Speaker walk in slides
Melissa Armstrong, MD, MSc, FAAN
07:35 AM - 08:10 AM PDT Speaker Diagnostic Tests and Biomarkers for Lewy Body Dementia
Ryan A. Townley, MD
08:10 AM - 08:45 AM PDT Speaker Pharmacologic and Non-pharmacologic Strategies for Treating Lewy Body Dementia
Melissa Armstrong, MD, MSc, FAAN
08:45 AM - 09:00 AM PDT Q&A Questions and Answers
Melissa Armstrong, MD, MSc, FAAN, Samantha K. Holden, MD, MS, FAAN, Ryan A. Townley, MD
Faculty Disclosures
Melissa Armstrong, MD, MSc, FAAN The institution of Dr. Armstrong has received research support from National Institute of Aging. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. Dr. Armstrong has received research support from Parkinson Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Samantha K. Holden, MD, MS, FAAN Dr. Holden has nothing to disclose.
Ryan A. Townley, MD Dr. Townley has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AAN.